Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multiple Arm, Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase 2 Study of Intra-Articular Administration of an Allogeneic Human Placental Tissue Particulate (PTP-001) for the Treatment of Knee Osteoarthritis

NCT05100225 is registered in ClinicalTrials.gov with Bioventus LLC as lead sponsor.

NCT NCT05100225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05100225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multiple Arm, Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm, Phase 2 Study of Intra-Articular Administration of an Allogeneic Human Placental Tissue Particulate (PTP-001) for the Treatment of Knee Osteoarthritis
Lead sponsor
Bioventus LLC
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 30, 2021
Completion date
November 30, 2022
Enrollment
210 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee